Big Pharma Stocks Spiral After Trump Officially Nominates RFK “Health Swamp Officer”

Donald Trump just sucker-punched Big Pharma, and let’s be honest, it had it coming. On Thursday, the president-elect tapped Robert F. Kennedy Jr. as his health secretary, leaving Wall Street in full panic mode (cue the sad violins). 

Shares of Moderna fell 5.6%, Pfizer slid 2.6%, and AstraZeneca wasn’t far behind, down 3%. Even Europe’s pharmaceutical monopolies like GSK and Sanofi got caught in the crossfire, each losing over 3%. (Somebody call HR—Big Pharma’s going to need a group therapy session.)

RFK Jr. isn’t here to play by the rules (especially not the ones Big Pharma wrote). Critics love to call him a conspiracy theorist and everyone has a right to their own opinions, but maybe that’s just code for “he’s asking the questions they don’t want to answer.” Think about it—Kennedy’s spent years railing against vaccines, pointing out the questionable ties between drug companies and regulators. Conflict of interest? You don’t say.

Kennedy’s nonprofit, Children’s Health Defense, has been a thorn in the side of the pharmaceutical industry for years. He’s not saying vaccines should disappear—he’s saying they need to be held accountable. (Crazy idea, right? Like, maybe don’t cut corners when injecting stuff into people’s arms.) 

Kennedy’s not stopping at vaccines. He’s gunning for a ban on fluoride in drinking water, pushing to remove harmful food additives, and advocating for healthier school lunches. Critics call these ideas extreme, but is it really radical to want cleaner water and better food for kids? If anything, it’s the kind of shake-up that’s long overdue in a system that prioritizes corporate profits over public health.

(Source: Law & Crime)

Trump, never one to shy away from theatrics, told Kennedy to “go wild” on health policy. Wall Street’s sweating like it just got called into the principal’s office. JP Morgan analysts even issued a warning: Kennedy’s leadership could derail the pharmaceutical gravy train. (Translation: They’re scared he’ll turn off the cash faucet they’ve been guzzling from for decades.)

(Source: RFK)

Trump’s beef with Big Pharma didn’t start yesterday. He’s long accused drug companies of playing politics, even claiming that they delayed vaccine trial results to hurt his 2020 election chances. Whether you agree or not, his choice of Kennedy feels like a calculated move to put the industry on notice: the days of unchecked influence and sky-high profits might be numbered.

Sure, Kennedy’s critics are loud. Some, like Congressman Robert Garcia, have even called the nomination “f***ing insane.” But maybe that’s because they see the writing on the wall: Kennedy isn’t afraid to ruffle feathers, and his leadership could expose the cracks in an industry that’s grown too powerful for its own good.

Of course, this isn’t to say that vaccine makers and their vaccines are all bad, but Big Pharma better brace itself. The swamp is about to get drained, and RFK Jr. just turned on the pump.

P.S. Life comes at you fast friends, and while your favorite online stock guru is out here struggling to make heads or tails on the markets short-term direction - our team and our premium members at Stocks.News are absolutely CRUSHING it. How so? Well it all comes down to back-to-back-to-back-to-back-to-back massive wins over the last few weeks. Don’t believe me? Click here to see for yourself when we drop the next one.

Stock.News has positions in Moderna.